Clinical Trials Logo

Pre-diabetes clinical trials

View clinical trials related to Pre-diabetes.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT05730582 Enrolling by invitation - Clinical trials for Diabetes Mellitus, Type 2

Increasing Uptake of EHR-enabled Population Health Outreach Strategies to Improve Diabetes Screening

Start date: March 5, 2024
Phase: N/A
Study type: Interventional

The study team's central hypothesis is that the Parkland Diabetes Detection Program (PDDP) screening invitations targeted by race/ethnicity with culturally concordant messaging and tailored by glycemic risk (known PDM vs. unknown glycemic state) plus phone-based navigation of non-responders will be more effective at closing screening gaps than PDDP generic screening invitations and usual care, opportunistic screening alone.

NCT ID: NCT05583045 Enrolling by invitation - Clinical trials for Diabetes Mellitus, Type 2

Prediabetes Intervention With Tea

PREVENT
Start date: November 1, 2022
Phase: N/A
Study type: Interventional

The goal of this interventional study is investigating the effect of the daily consumption of olive leaves tea on glycemic control of individuals diagnosed with pre-diabetes. The hypothesis of this study is that the integration of olive leaf tea on daily food consumption will favors glycemic control and ameliorate insulin resistance in individuals with pre-diabetes.

NCT ID: NCT05367024 Enrolling by invitation - Pre-diabetes Clinical Trials

Broccoli Effect on Glycated Haemoglobin (HbA1c)

BETA
Start date: September 27, 2021
Phase: N/A
Study type: Interventional

Broccoli has shown to normalise elevated blood sugars when eaten over long period of time. Individuals with pre-diabetes have higher than normal blood sugar levels. In this study, investigators are trying to understand how broccoli, when eaten as a soup, affects blood sugar levels in individuals with pre-diabetes.

NCT ID: NCT03389100 Enrolling by invitation - Clinical trials for Diabetes Mellitus, Type 2

Tau PET Imaging in the Northern Manhattan Study of Metabolism and Mind.

NOMEM-Tau
Start date: July 24, 2018
Phase: Phase 2
Study type: Interventional

This is a single center brain Positron Emission Tomography (PET) study of 18F-MK-6240. Eligible participants are persons from Northern Manhattan who self-identify as Hispanic, non-Hispanic Black, or Non-Hispanic White, who are 55 to 69 years of age, of both sexes, without dementia, who have already agreed to undergo, of have undergone, brain amyloid PET and magnetic resonance imaging (MRI). Those eligible will have one brain PET scan with 18F-MK-6240, repeated after 18 months to 30 months. Vital signs will be checked prior to injection of 18F-MK-6240 and again at the completion of the PET scan. The primary objective is to relate diabetes status and glycemia to in-vivo brain tau accumulation, across and within ethnic and racial groups.